Roivant Sciences Ltd
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Shareholder voteSep 18 →InsidersNo open-market buys. 12 insiders sold $648.3M, 18 of 81 sales on a 10b5-1 plan.→PeersClosest companies: VRDN, BBIO, MREO→
From the filings
Figures
- Revenue
- $7.5Mlast 12 months
- Net income
- −$266.3Mlast 12 months
- Operating cash flow
- −$816.5Mlast 12 months
- Cash and equivalents
- $1.25Bat the last balance sheet
- Shares outstanding
- 722.7M shareson issue